ADS Smart Trial
Study / Research
A new trial in England studying two medicines, Metformin and Strattera, for Alzheimer's disease, shifting focus from beta-amyloid to metabolism.
Mentioned in 1 video
A new trial in England studying two medicines, Metformin and Strattera, for Alzheimer's disease, shifting focus from beta-amyloid to metabolism.